CAS 1189455-63-7

Loxapine-d8

CAS: 1189455-63-7

Formula: C₁₈H₁₀D₈ClN₃O

Color and Shape: Off-White Solid

Molecular weight: 335.86

Ref: 4Z-L-089002

Loxapine-d8

Controlled Product

CAS: 1189455-63-7

Loxapine-d8 is an analog of Loxapine, a medication used to treat psychiatric disorders such as schizophrenia. However, Loxapine-d8 has been found to have potential anticancer properties. It inhibits the activity of kinases, which are enzymes that play a crucial role in the development and progression of cancer. Additionally, Loxapine-d8 has been shown to induce apoptosis (programmed cell death) in cancer cells, making it a promising candidate for cancer treatment. This compound also acts as an inhibitor of elastase, an enzyme involved in tissue damage and inflammation. Loxapine-d8 is excreted in urine and has shown efficacy against various types of tumors including Chinese hamster ovary cells. With its unique characteristics and potential therapeutic benefits, Loxapine-d8 is a promising candidate for further research and development as an anticancer agent.

Formula: C₁₈H₁₈ClN₃O

Purity: Min. 95%

Molecular weight: 335.9 g/mol

Ref: 3D-PXB45563